1726 related articles for article (PubMed ID: 29895977)
21. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stromal cells: current understanding and clinical status.
Salem HK; Thiemermann C
Stem Cells; 2010 Mar; 28(3):585-96. PubMed ID: 19967788
[TBL] [Abstract][Full Text] [Related]
23. The Unique Immunomodulatory Properties of MSC-Derived Exosomes in Organ Transplantation.
Zheng Q; Zhang S; Guo WZ; Li XK
Front Immunol; 2021; 12():659621. PubMed ID: 33889158
[TBL] [Abstract][Full Text] [Related]
24. Key Metabolic Pathways in MSC-Mediated Immunomodulation: Implications for the Prophylaxis and Treatment of Graft Versus Host Disease.
Burnham AJ; Foppiani EM; Horwitz EM
Front Immunol; 2020; 11():609277. PubMed ID: 33365034
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease.
Fan X; Guo D; Cheung AMS; Poon ZY; Yap CS; Goh SE; Guo D; Li H; Bari S; Li S; Lim KH; Hwang WYK
Biol Blood Marrow Transplant; 2018 Oct; 24(10):1971-1980. PubMed ID: 29883796
[TBL] [Abstract][Full Text] [Related]
27. MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism.
Planat-Benard V; Varin A; Casteilla L
Front Immunol; 2021; 12():626755. PubMed ID: 33995350
[TBL] [Abstract][Full Text] [Related]
28. Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease.
Kim KW; Moon SJ; Park MJ; Kim BM; Kim EK; Lee SH; Lee EJ; Chung BH; Yang CW; Cho ML
Stem Cell Res Ther; 2015 Oct; 6():202. PubMed ID: 26497134
[TBL] [Abstract][Full Text] [Related]
29. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
Reinders ME; Fibbe WE; Rabelink TJ
Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
[TBL] [Abstract][Full Text] [Related]
30. Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications.
Lee DK; Song SU
Cell Immunol; 2018 Apr; 326():68-76. PubMed ID: 28919171
[TBL] [Abstract][Full Text] [Related]
31. Immunomodulatory properties of mesenchymal stem cells: cytokines and factors.
Soleymaninejadian E; Pramanik K; Samadian E
Am J Reprod Immunol; 2012 Jan; 67(1):1-8. PubMed ID: 21951555
[TBL] [Abstract][Full Text] [Related]
32. Emerging role of mesenchymal stem cells during tuberculosis: The fifth element in cell mediated immunity.
Khan A; Hunter RL; Jagannath C
Tuberculosis (Edinb); 2016 Dec; 101S():S45-S52. PubMed ID: 27743705
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal Stromal Cells Modulate Peripheral Stress-Induced Innate Immune Activation Indirectly Limiting the Emergence of Neuroinflammation-Driven Depressive and Anxiety-like Behaviors.
Gallagher D; Siddiqui F; Fish J; Charlat M; Chaudry E; Moolla S; Gauthier-Fisher A; Librach C
Biol Psychiatry; 2019 Nov; 86(9):712-724. PubMed ID: 31521333
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stem cells as immunomodulator therapies for immune-mediated systemic dermatoses.
Reddy BY; Xu DS; Hantash BM
Stem Cells Dev; 2012 Feb; 21(3):352-62. PubMed ID: 21864110
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic Potential of Mesenchymal Stem Cells in Immune-Mediated Diseases.
Eljarrah A; Gergues M; Pobiarzyn PW; Sandiford OA; Rameshwar P
Adv Exp Med Biol; 2019; 1201():93-108. PubMed ID: 31898783
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal stem cells increase skin graft survival time and up-regulate PD-L1 expression in splenocytes of mice.
Moravej A; Geramizadeh B; Azarpira N; Zarnani AH; Yaghobi R; Kalani M; Khosravi M; Kouhpayeh A; Karimi MH
Immunol Lett; 2017 Feb; 182():39-49. PubMed ID: 28069488
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulation effect of mesenchymal stem cells in islet transplantation.
Shrestha M; Nguyen TT; Park J; Choi JU; Yook S; Jeong JH
Biomed Pharmacother; 2021 Oct; 142():112042. PubMed ID: 34403963
[TBL] [Abstract][Full Text] [Related]
38. In vitro And In vivo Immunomodulating Properties of Mesenchymal Stem Cells.
Chaudhary D; Trivedi RN; Kathuria A; Goswami TK; Khandia R; Munjal A
Recent Pat Inflamm Allergy Drug Discov; 2018; 12(1):59-68. PubMed ID: 29485014
[TBL] [Abstract][Full Text] [Related]
39. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase.
Meisel R; Brockers S; Heseler K; Degistirici O; Bülle H; Woite C; Stuhlsatz S; Schwippert W; Jäger M; Sorg R; Henschler R; Seissler J; Dilloo D; Däubener W
Leukemia; 2011 Apr; 25(4):648-54. PubMed ID: 21242993
[TBL] [Abstract][Full Text] [Related]
40. Human foreskin fibroblasts exert immunomodulatory properties by a different mechanism to bone marrow stromal/stem cells.
Wada N; Bartold PM; Gronthos S
Stem Cells Dev; 2011 Apr; 20(4):647-59. PubMed ID: 20712449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
